ANTIOXIDANT ACTIVITY OF SEED EXTRACT OF PSORALEA CORYLIFOLIA LINN.
Journal Title: Asian Journal of Pharmaceutical Education and Research - Year 2018, Vol 7, Issue 2
Abstract
The present study aimed to characterize the hydroalcoholic extracts prepared from seed of Psoralea corylifolia linn. The antioxidant potential of extract was evaluated using DPPH in vitro antioxidant models. This study, has to some extent, validated the medicinal potential of the seed of Psoralea corylifolia linn. Further studies are necessary to evaluate the in vivo antioxidant potential of the tested extracts, but the in vitro experiments already performed and confirmed as potential health source.
Authors and Affiliations
Dr. Roli Shukla
AN OVERVIEW OF CONGESTIVE HEART FAILURE AND ITS NOVEL TREATMENT APPROACHES
Congestive heart failure (CHF) is a common clinical disorder that results in pulmonary vascular congestion with reduced cardiac output and describes the inability of the heart to meet the needs of organs and tissues for...
DEVELOPMENT AND EVALUATION OF TOPICAL LIPOSOMAL GEL LOADED WITH TAZAROTENE IN COMBINATION WITH HYDROQUINONE
The aim of the present study was to statistically optimize the vesicular formulations (Liposomes) for enhanced skin delivery of a model drug tazarotene in combination with gel contains hydroquinone. Regular 23 factorial...
REVIEW ON NANO EMULSION BASED DRUG DELIVERY SYSTEM
The most emerging branch in pharmaceutical sciences known as “Pharmaceutical nanotechnology” presents new tools, opportunities and scope, which are expected to have significant applications in disease diagnostics and the...
DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF AMOXICILLIN TRIHYDRATE, METRONIDAZOLE AND FAMOTIDINE
The objective of the current study was to develop and validate a simple, accurate, precise and rapid reversed-phase HPLC method for simultaneous estimation of Amoxicillin trihydrate (AMOX), Metronidazole (METRO) and Famo...
ACENOCOUMAROL (NICOUMALONE) INDUCED GASTROINTESTINAL BLEEDING
Nicoumalone is an oral vitamin K antagonist prescribed for the prevention and treatment of venous thromboembolism. The major challenge faced during the therapy were control of bleeding and identification of risk factor w...